Barrington, RI, United States of America

Qian Chen

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Qian Chen

Introduction

Qian Chen is a prominent inventor based in Barrington, Rhode Island, known for his significant contributions to the field of medical science. With a total of 11 patents to his name, he has made remarkable advancements in the development of therapeutic and diagnostic agents.

Latest Patents

Among his latest patents, one notable invention is focused on nanocarriers and their processing for diagnostics and therapeutics. This invention provides compositions and methods for preferential targeting of tissues to deliver therapeutic or diagnostic agents. Such compounds are particularly useful in treating joint disorders, including injury-induced osteoarthritis and autoimmune diseases like rheumatoid arthritis. Another significant patent involves compositions and methods for treating articulating joint disorders with nucleoside reverse transcriptase inhibitors. This invention describes the systemic administration of a nucleoside reverse transcriptase inhibitor (NRTI) to treat articulating joint disorders effectively.

Career Highlights

Qian Chen has worked with esteemed institutions such as Rhode Island Hospital and Brown University. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Qian has collaborated with notable colleagues, including Yupeng Chen and Hongchuan Yu, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Qian Chen's innovative work in the medical field, particularly in joint disorder treatments, showcases his dedication to improving healthcare through science and technology. His patents reflect a commitment to advancing therapeutic methods that can significantly benefit patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…